The implantable loop recorder (ILR) is a subcutaneous, single-lead, electrocardiographic (ECG) monitoring device used for diagnosis in patients with recurrent unexplained episodes of palpitations or syncope, for long-term monitoring in patients at risk for or with documented atrial fibrillation (AF), and for risk stratification in patients who have sustained a myocardial infarction (MI) and those who have certain genetic disorders.
The device is capable of storing ECG data automatically in response to a significant bradyarrhythmia or tachyarrhythmia or in response to patient activation. It is particularly useful either when symptoms are infrequent (and thus not amenable to diagnosis using short-term external ECG recording techniques).
The device is typically implanted under the skin, in the left side of chest.
Indications
- unexplained, repetead syncope (loss of conciousness)
- palpitations
- risk stratification post myocardial infarction
- patients with or at risk for atrial fibrillation
- dizziness
Contraindications
- The presence of an active infection or a bleeding diathesis may preclude implantation.
- As I pointed above, altough long term monitoring is useful for diagnosis when symptoms are rare, there are also some disadvantages:
- the need for a minor surgical procedure
- the difficulty of always being able to differentiate arrythmia’s orogin ( supraventricular from ventricular arrhythmias)
- malfunction may exhaust the memory of the ILR
- the cost of the device – the ILR has a high initial cost; however, it may actually be more cost-effective than a strategy incorporating multiple nondiagnostic investigations. Although symptom-rhythm correlation can be obtained in the vast majority of patients, about 25 % of all patients remain without definite diagnosis despite the use of ILR. In addition the need for proper patient selection is high.